Skip to main content
Top
Published in: Annals of Hematology 11/2008

01-11-2008 | Original Article

Profile of Th17 cytokines (IL-17, TGF-β, IL-6) and Th1 cytokine (IFN-γ) in patients with immune thrombocytopenic purpura

Authors: Daoxin Ma, Xiaojuan Zhu, Ping Zhao, Chunhong Zhao, Xiaofang Li, Yuanyuan Zhu, Lizhen Li, Jianzhi Sun, Jun Peng, Chunyan Ji, Ming Hou

Published in: Annals of Hematology | Issue 11/2008

Login to get access

Abstract

The data on polarization of the immune system towards T helper 1 (Th1) or T helper 2 (Th2) cells in immune thrombocytopenic purpura (ITP) are limited and contradictory. Th17 characterized by the production of Interleukin 17 (IL-17) has been shown to play a crucial part in the induction of autoimmune diseases. To further investigate the role of Th cytokines in the pathogenesis of ITP, we measured the plasma concentration of three Th17-associated cytokines [IL-17, transforming growth factor-ß (TGF-ß), IL-6] and Th1 cytokine interferon-γ (IFN-γ) in ITP patients, and evaluated their clinical relevance. The concentration of IL-17, TGF-ß, IL-6, and IFN-γ in plasma specimens from 29 adults with chronic ITP and 38 controls was analyzed by enzyme-linked immunosorbent assay method. No significant differences of Th17 cytokines (IL-17, TGF-ß, and IL-6) and Th1 cytokine (IFN-γ) concentration were observed between patients with active ITP and the control group. And the IFN-γ/IL-17 ratio representing Th1/Th17 cytokine profile was not significantly different between ITP patients and control, either. However, significantly positive correlation between IL-6 and IFN-γ in ITP patients was observed (r = 0.48, P = 0.01). Among the ITP patients, Plasma IL-17 levels in male were marginally higher than those in female, while similar for TGF-ß, IL-6 or IFN-γ. There was a significantly positive correlation between age and IL-6 concentration in ITP patients (r = 0.56, P = 0.0002), while no statistical significance between age and the other three cytokines. No significant correlation between cytokine concentrations and platelets or megakaryocytes number was found in ITP patients. In summary, ITP may not be associated with changes of plasma Th17 and Th1 cytokine concentrations relative to control population.
Literature
1.
go back to reference Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL (2003) Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 278:1910–1914 doi:10.1074/jbc.M207577200 PubMedCrossRef Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL (2003) Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 278:1910–1914 doi:10.​1074/​jbc.​M207577200 PubMedCrossRef
2.
go back to reference Andersson PO, Stockelberg D, Jacobsson S, Wadenvik H (2000) A transforming growth factor-beta1-mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpura. Ann Hematol 79:507–513 doi:10.1007/s002770000177 PubMedCrossRef Andersson PO, Stockelberg D, Jacobsson S, Wadenvik H (2000) A transforming growth factor-beta1-mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpura. Ann Hematol 79:507–513 doi:10.​1007/​s002770000177 PubMedCrossRef
3.
go back to reference Butrimiene I, Jarmalaite S, Ranceva J, Venalis A, Jasiuleviciute L, Zvirbliene A (2004) Different cytokine profiles in patients with chronic and acute reactive arthritis. Rheumatology (Oxford) 43:1300–1304 doi:10.1093/rheumatology/keh323 CrossRef Butrimiene I, Jarmalaite S, Ranceva J, Venalis A, Jasiuleviciute L, Zvirbliene A (2004) Different cytokine profiles in patients with chronic and acute reactive arthritis. Rheumatology (Oxford) 43:1300–1304 doi:10.​1093/​rheumatology/​keh323 CrossRef
5.
go back to reference Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B et al (2003) Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421:744–748 doi:10.1038/nature01355 PubMedCrossRef Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B et al (2003) Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421:744–748 doi:10.​1038/​nature01355 PubMedCrossRef
7.
go back to reference George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ et al (1996) Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 88:3–40PubMed George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ et al (1996) Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 88:3–40PubMed
8.
go back to reference Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM et al (2005) Interleukin 17-producing CD4(+) effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123–1132 doi:10.1038/ni1254 PubMedCrossRef Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM et al (2005) Interleukin 17-producing CD4(+) effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123–1132 doi:10.​1038/​ni1254 PubMedCrossRef
9.
go back to reference Hoffman R, Zaknoen S, Yang HH, Bruno E, LoBuglio AF, Arrowsmith JB et al (1985) An antibody cytotoxic to megakaryocyte progenitor cells in a patient with immune thrombocytopenic purpura. N Engl J Med 312:1170–1174PubMed Hoffman R, Zaknoen S, Yang HH, Bruno E, LoBuglio AF, Arrowsmith JB et al (1985) An antibody cytotoxic to megakaryocyte progenitor cells in a patient with immune thrombocytopenic purpura. N Engl J Med 312:1170–1174PubMed
10.
go back to reference Karlsson FA, Berne C, Björk E, Kullin M, Li Z, Ma JY et al (2000) Beta-cell activity and destruction in type 1 diabetes. Ups J Med Sci 105:85–95PubMed Karlsson FA, Berne C, Björk E, Kullin M, Li Z, Ma JY et al (2000) Beta-cell activity and destruction in type 1 diabetes. Ups J Med Sci 105:85–95PubMed
11.
go back to reference Hirota K, Hashimoto M, Yoshitomi H, Tanaka S, Nomura T, Yamaguchi T, Iwakura Y, Sakaguchi N, Sakaguchi S (2007) T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J Exp Med 204:41–47 doi:10.1084/jem.20062259 PubMedCrossRef Hirota K, Hashimoto M, Yoshitomi H, Tanaka S, Nomura T, Yamaguchi T, Iwakura Y, Sakaguchi N, Sakaguchi S (2007) T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J Exp Med 204:41–47 doi:10.​1084/​jem.​20062259 PubMedCrossRef
13.
16.
go back to reference Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA et al (2003) Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198:1951–1957 doi:10.1084/jem.20030896 PubMedCrossRef Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA et al (2003) Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198:1951–1957 doi:10.​1084/​jem.​20030896 PubMedCrossRef
17.
go back to reference Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, Homma I et al (2002) Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17:375–387 doi:10.1016/S1074-7613(02)00391-6 PubMedCrossRef Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, Homma I et al (2002) Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17:375–387 doi:10.​1016/​S1074-7613(02)00391-6 PubMedCrossRef
18.
go back to reference Nomura S, Yanabu M, Kido H, Lan XG, Ichiyoshi H, Katsura K et al (1995) Significance of cytokines and CD68-positive microparticles in immune thrombocytopenic purpura. Eur J Haematol 55:49–56PubMedCrossRef Nomura S, Yanabu M, Kido H, Lan XG, Ichiyoshi H, Katsura K et al (1995) Significance of cytokines and CD68-positive microparticles in immune thrombocytopenic purpura. Eur J Haematol 55:49–56PubMedCrossRef
20.
go back to reference Panitsas FP, Theodoropoulou M, Kouraklis A, Karakantza M, Theodorou GL, Zoumbos NC et al (2004) Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response. Blood 103:2645–2647 doi:10.1182/blood-2003-07-2268 PubMedCrossRef Panitsas FP, Theodoropoulou M, Kouraklis A, Karakantza M, Theodorou GL, Zoumbos NC et al (2004) Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response. Blood 103:2645–2647 doi:10.​1182/​blood-2003-07-2268 PubMedCrossRef
21.
go back to reference Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH et al (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6:1133–1141 doi:10.1038/ni1261 PubMedCrossRef Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH et al (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6:1133–1141 doi:10.​1038/​ni1261 PubMedCrossRef
22.
go back to reference Stahl CP, Zucker-Franklin D, McDonald TP (1986) Incomplete antigenic cross-reactivity between platelets and megakaryocytes: relevance to ITP. Blood 67:421–428PubMed Stahl CP, Zucker-Franklin D, McDonald TP (1986) Incomplete antigenic cross-reactivity between platelets and megakaryocytes: relevance to ITP. Blood 67:421–428PubMed
23.
go back to reference Stasi R, Del Poeta G, Stipa E, Evangelista ML, Trawinska MM, Cooper N et al (2007) Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura. Blood 110:2924–2930 doi:10.1182/blood-2007-02-068999 PubMedCrossRef Stasi R, Del Poeta G, Stipa E, Evangelista ML, Trawinska MM, Cooper N et al (2007) Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura. Blood 110:2924–2930 doi:10.​1182/​blood-2007-02-068999 PubMedCrossRef
24.
go back to reference Vainchenker W, Deschamps JF, Bastin JM, Guichard J, Titeux M, Breton-Gorius J et al (1982) Two monoclonal antiplatelet antibodies as markers of human megakaryocyte maturation: immunofluorescent staining and platelet peroxidase detection in megakaryocyte colonies and in vivo cells from normal and leukemia patients. Blood 59:514–521PubMed Vainchenker W, Deschamps JF, Bastin JM, Guichard J, Titeux M, Breton-Gorius J et al (1982) Two monoclonal antiplatelet antibodies as markers of human megakaryocyte maturation: immunofluorescent staining and platelet peroxidase detection in megakaryocyte colonies and in vivo cells from normal and leukemia patients. Blood 59:514–521PubMed
25.
go back to reference Wang HL (2003) Clinical hematologic analysis. In: Cheng WB, Wang YC (eds) Diagnostics, 5th Ed. The People’s Health, Peking, pp 301–302 (In Chinese) Wang HL (2003) Clinical hematologic analysis. In: Cheng WB, Wang YC (eds) Diagnostics, 5th Ed. The People’s Health, Peking, pp 301–302 (In Chinese)
26.
go back to reference Wang T, Zhao H, Ren H, Guo J, Xu M, Yang R et al (2005) Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura. Haematologica 90:914–923PubMed Wang T, Zhao H, Ren H, Guo J, Xu M, Yang R et al (2005) Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura. Haematologica 90:914–923PubMed
28.
go back to reference Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B et al (2006) IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 116:1310–1316 doi:10.1172/JCI21404 PubMedCrossRef Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B et al (2006) IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 116:1310–1316 doi:10.​1172/​JCI21404 PubMedCrossRef
Metadata
Title
Profile of Th17 cytokines (IL-17, TGF-β, IL-6) and Th1 cytokine (IFN-γ) in patients with immune thrombocytopenic purpura
Authors
Daoxin Ma
Xiaojuan Zhu
Ping Zhao
Chunhong Zhao
Xiaofang Li
Yuanyuan Zhu
Lizhen Li
Jianzhi Sun
Jun Peng
Chunyan Ji
Ming Hou
Publication date
01-11-2008
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 11/2008
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-008-0535-3

Other articles of this Issue 11/2008

Annals of Hematology 11/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.